| Ytd | 25.70% | |
| 1y | 7.64% |
| Open | 284.13 | Prev Close | 286.10 | Low | 282.28 | High | 284.13 | Mkt Cap | 1.46B |
| Vol | 6.29K | Avg Vol | 37.56K | EPS | 10.82 | P/E | 26.44 | Forward P/E | 35.59 |
| Beta | 0.76 | Short Ratio | 8.81 | Inst. Own | 39.61% | Dividend | 18.00 | Div Yield | 6.39 |
| Ex Div Date | 05-11 | Earning | 08-03 | 50-d Avg | 260.05 | 200-d Avg | 239.64 | 1yr Est | 190.00 |
PARAMUS, N.J., July 21, 2026 (GLOBE NEWSWIRE) -- Alexander's, Inc. (NYSE: ALX) today announced that
SOUTH SAN FRANCISCO, Calif., June 30, 2026 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc. ("ALX Onco
Strengthens Leadership with Veteran Executives with Decades of Industry Experience Scott Garland Suc
PARAMUS, N. J. , June 29, 2026 (GLOBE NEWSWIRE) -- Alexander's, Inc. (NYSE: ALX) announced today tha
VANCOUVER, British Columbia, June 16, 2026 (GLOBE NEWSWIRE) -- Greenridge Exploration Inc. (“Greenri
SOUTH SAN FRANCISCO, Calif., June 01, 2026 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc. ("ALX Onco
PARAMUS, N. J. , May 28, 2026 (GLOBE NEWSWIRE) -- Alexander's, Inc. (NYSE: ALX) announced today that
Let's capitalize on analyst incompetence—and bank yields up to 18.3%, with upside to boot!
https://www.bloomberg.com/news/articles/2026-05-12/mamdani-scraps-planned-nyc-property-tax-hike-in-r
ALX Oncology NASDAQ: ALXO executives used the company's first-quarter 2026 earnings call to highligh
- Data from Phase 1b/2 trial of evorpacept + zanidatamab presented at ESMO Breast Cancer 2026 showed
- Data from Phase 1b/2 trial presented at ESMO Breast Cancer 2026 further validate a biomarker-drive
Alexander's (ALX) came out with quarterly funds from operations (FFO) of $2.6 per share, missing the
On May 01, 2026, Alexander's Inc (ALX) shares fell 3.0%, closing at $244.34. The stock has traded wi
- Company Will Discuss Data and Report First Quarter 2026 Financial Results on May 8 - SOUTH SAN FRA
PARAMUS, N.J., April 29, 2026 (GLOBE NEWSWIRE) -- Alexander's, Inc. (NYSE: ALX) today announced that
PARAMUS, N.J., April 21, 2026 (GLOBE NEWSWIRE) -- Alexander's, Inc. (NYSE: ALX) today announced that
SOUTH SAN FRANCISCO, Calif., April 17, 2026 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc. (“ALX Onc
Alcoholic beverage company Boston Beer was a contributor for the quarter as industry data improved c
Companies Reporting Before The Bell • HSBC Holdings (NYSE:HSBC) is likely to report earnings for it
Companies Reporting Before The Bell • Immunogen (NASDAQ:IMGN) is estimated to report quarterly loss
On Monday, 85 stocks hit new 52-week lows.
Companies Reporting Before The Bell • TG Therapeutics (NASDAQ:TGTX) is estimated to report quarterl
Companies Reporting Before The Bell • Insperity (NYSE:NSP) is estimated to report quarterly earning
On Thursday, 930 stocks hit new 52-week lows.
On Wednesday, 329 companies hit new 52-week lows.
Stocks That Hit 52-Week Lows On Thursday
Stocks That Hit 52-Week Lows On Wednesday
Stocks That Hit 52-Week Lows On Thursday
Stocks That Hit 52-Week Lows On Thursday
Stocks Which Set New 52-Week Low Yesterday, October 31st